Suppr超能文献

年轻非肥胖 II 型糖尿病 Goto-Kakizaki 大鼠的勃起功能障碍与 eNOS 丝氨酸 1177 磷酸化减少有关。

Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177.

机构信息

Department of Physiology, Medical College of Georgia, Augusta, GA, USA.

出版信息

J Sex Med. 2010 Nov;7(11):3620-34. doi: 10.1111/j.1743-6109.2010.02000.x. Epub 2010 Aug 30.

Abstract

INTRODUCTION

Diabetes mellitus (DM) is a risk factor for erectile dysfunction (ED). Although type 2 DM is responsible for 90-95% diabetes cases, type 1 DM experimental models are commonly used to study diabetes-associated ED.

AIM

Goto-Kakizaki (GK) rat model is relevant to ED studies since the great majority of patients with type 2 diabetes display mild deficits in glucose-stimulated insulin secretion, insulin resistance, and hyperglycemia. We hypothesized that GK rats display ED which is associated with decreased nitric oxide (NO) bioavailability.

METHODS

Wistar and GK rats were used at 10 and 18 weeks of age. Changes in the ratio of intracavernosal pressure/mean arterial pressure (ICP/MAP) after electrical stimulation of cavernosal nerve were determined in vivo. Cavernosal contractility was induced by electrical field stimulation (EFS) and phenylephrine (PE). In addition, nonadrenergic-noncholinergic (NANC)- and sodium nitroprusside (SNP)-induced relaxation were determined. Cavernosal neuronal nitric oxide synthase (nNOS) and endothelial nitric oxide synthase (eNOS) mRNA and protein expression were also measured.

MAIN OUTCOME MEASURE

GK diabetic rats display ED associated with decreased cavernosal expression of eNOS protein.

RESULTS

GK rats at 10 and 18 weeks demonstrated impaired erectile function represented by decreased ICP/MAP responses. Ten-week-old GK animals displayed increased PE responses and no changes in EFS-induced contraction. Conversely, contractile responses to EFS and PE were decreased in cavernosal tissue from GK rats at 18 weeks of age. Moreover, GK rats at 18 weeks of age displayed increased NANC-mediated relaxation, but not to SNP. In addition, ED was associated with decreased eNOS protein expression at both ages.

CONCLUSION

Although GK rats display ED, they exhibit changes in cavernosal reactivity that would facilitate erectile responses. These results are in contrast to those described in other experimental diabetes models. This may be due to compensatory mechanisms in cavernosal tissue to overcome restricted pre-penile arterial blood supply or impaired veno-occlusive mechanisms.

摘要

简介

糖尿病(DM)是勃起功能障碍(ED)的一个危险因素。虽然 2 型 DM 占糖尿病病例的 90-95%,但常使用 1 型 DM 实验模型来研究与糖尿病相关的 ED。

目的

Goto-Kakizaki(GK)大鼠模型与 ED 研究相关,因为大多数 2 型糖尿病患者表现出葡萄糖刺激的胰岛素分泌、胰岛素抵抗和高血糖的轻度缺陷。我们假设 GK 大鼠表现出 ED,其与一氧化氮(NO)生物利用度降低有关。

方法

10 周和 18 周龄时使用 Wistar 和 GK 大鼠。通过电刺激海绵体神经来确定体内海绵体内压/平均动脉压(ICP/MAP)比值的变化。用电场刺激(EFS)和苯肾上腺素(PE)诱导海绵体收缩。此外,还测定了非肾上腺素非胆碱能(NANC)和硝普钠(SNP)诱导的松弛。还测量了海绵体神经元型一氧化氮合酶(nNOS)和内皮型一氧化氮合酶(eNOS)mRNA 和蛋白表达。

主要观察结果

GK 糖尿病大鼠表现出与海绵体 eNOS 蛋白表达降低相关的 ED。

结果

10 周和 18 周时的 GK 大鼠表现出勃起功能受损,表现为 ICP/MAP 反应降低。10 周龄的 GK 动物表现出对 PE 反应增加,而 EFS 诱导的收缩无变化。相反,18 周龄 GK 大鼠的海绵体组织对 EFS 和 PE 的收缩反应降低。此外,18 周龄的 GK 大鼠表现出增加的 NANC 介导的松弛,但对 SNP 无反应。此外,ED 与两个年龄段的 eNOS 蛋白表达降低有关。

结论

尽管 GK 大鼠表现出 ED,但它们表现出海绵体反应的变化,这有利于勃起反应。这些结果与其他实验性糖尿病模型中描述的结果相反。这可能是由于海绵体组织中的代偿机制,以克服阴茎前动脉血液供应受限或受损的静脉闭塞机制。

相似文献

1
3
Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.
J Sex Med. 2013 Sep;10(9):2154-64. doi: 10.1111/jsm.12245. Epub 2013 Jul 24.
4
The Favorable Effect of Empagliflozin on Erectile Function in an Experimental Model of Type 2 Diabetes.
J Sex Med. 2018 Sep;15(9):1224-1234. doi: 10.1016/j.jsxm.2018.07.002. Epub 2018 Aug 23.
5
Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.
J Sex Med. 2008 May;5(5):1156-1166. doi: 10.1111/j.1743-6109.2007.00752.x. Epub 2008 Jan 21.
6
Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta.
Mol Cell Biochem. 2009 Dec;332(1-2):95-102. doi: 10.1007/s11010-009-0178-2. Epub 2009 Jun 20.
9
Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2383-94. doi: 10.1152/ajpheart.00178.2011. Epub 2011 Sep 16.
10
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9121-6. doi: 10.1073/pnas.0400520101. Epub 2004 Jun 7.

引用本文的文献

1
Animal models in the study of diabetic erectile dysfunction: mechanisms and applications.
Front Endocrinol (Lausanne). 2025 Mar 24;16:1512360. doi: 10.3389/fendo.2025.1512360. eCollection 2025.
2
EXPERIMENTAL INDUCTION OF TYPE 2 DIABETES MELLITUS AND THE EFFICIENCY OF BARIATRIC SURGERY IN ITS REVERSAL IN RATS.
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):149-156. doi: 10.4183/aeb.2021.149.
3
Role of Glucose-Lowering Medications in Erectile Dysfunction.
J Clin Med. 2021 Jun 5;10(11):2501. doi: 10.3390/jcm10112501.
4
A novel experimental model of erectile dysfunction in rats with heart failure using volume overload.
PLoS One. 2017 Nov 2;12(11):e0187083. doi: 10.1371/journal.pone.0187083. eCollection 2017.
5
Penile alterations at early stage of type 1 diabetes in rats.
Int Braz J Urol. 2017 Jul-Aug;43(4):753-761. doi: 10.1590/S1677-5538.IBJU.2016.0454.
9
Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.
Nat Rev Urol. 2016 May;13(5):266-74. doi: 10.1038/nrurol.2016.23. Epub 2016 Feb 16.

本文引用的文献

1
Diabetes, obesity and erectile dysfunction: field overview and research priorities.
J Urol. 2009 Dec;182(6 Suppl):S45-50. doi: 10.1016/j.juro.2009.07.089.
2
Abdominal obesity and physical inactivity are associated with erectile dysfunction independent of body mass index.
J Sex Med. 2009 Jul;6(7):1990-8. doi: 10.1111/j.1743-6109.2009.01302.x. Epub 2009 Apr 28.
3
Diabetes, obesity, and erectile dysfunction.
Gend Med. 2009;6 Suppl 1:4-16. doi: 10.1016/j.genm.2008.12.003.
4
Type 1 and Type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease?
J Sex Med. 2009 Mar;6 Suppl 3:262-8. doi: 10.1111/j.1743-6109.2008.01183.x.
5
Beneficial impact of exercise and obesity interventions on erectile function and its risk factors.
J Sex Med. 2009 Mar;6 Suppl 3:254-61. doi: 10.1111/j.1743-6109.2008.01143.x.
6
Neuropeptides in the rat corpus cavernosum and seminal vesicle: effects of age and two types of diabetes.
Auton Neurosci. 2009 Mar 12;146(1-2):76-80. doi: 10.1016/j.autneu.2008.11.016. Epub 2009 Jan 17.
7
Review type 2 diabetes mellitus and erectile dysfunction.
J Sex Med. 2009 Apr;6(4):916-926. doi: 10.1111/j.1743-6109.2008.01116.x. Epub 2008 Dec 5.
8
Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.
Curr Pharm Des. 2008;14(25):2613-8. doi: 10.2174/138161208786071326.
9
Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
J Sex Med. 2008 Dec;5(12):2793-807. doi: 10.1111/j.1743-6109.2008.01009.x. Epub 2008 Sep 24.
10
Strain differences in susceptibility to in vivo erectile dysfunction following 6 weeks of induced hyperglycemia in the mouse.
J Sex Med. 2008 May;5(5):1149-1155. doi: 10.1111/j.1743-6109.2008.00787.x. Epub 2008 Mar 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验